# Laser Therapy-Guidance for Early Laryngeal Carcinoma

- Link: https://sifsof.com/clinical-apps/laser-therapy-guidance-for-early-laryngeal-carcinoma/
- Published: 2022-02-22T11:54:09+00:00
- Author: Monica

Early laryngeal cancer: In stages 0, 1, and 2, the tumor is small. Cancer has not
spread beyond the larynx. Laryngeal cancers that form on the vocal cords (glottis)
often cause hoarseness or a change in the voice.

 Removing cancer through surgery is a common treatment for all stages of laryngeal
cancer.

Laser therapy was pioneered in the early 1970s as an approach to treat laryngeal
pathology with precision and minimal thermal damage to the vocal cords.

Over the last four decades, LLT has become an integral part of the treatment paradigm
for patients with laryngeal cancer, especially with early-stage laryngeal tumors.

Undoubtedly, the quality of the laser devices used for treatment has been a determining
factor that strongly impacted the recovery’s quality and duration.

The [FDA Portable 980nm Surgery Laser System SIFLASER-1.2B](https://sifsof.com/product/fda-portable-980nm-surgery-laser-system-siflaser-1-2b/)
for example has been recurrently used by a number of otolaryngologists viewing its
high efficacy in treating such an issue.

This device’s blue laser light interacts better with the tissue components hemoglobin
or melanin. At 980 nm, the machine performs better and gentler cutting, even at 
lower power.

As such, its Improved cutting performance makes it ideally suited to all surgical
applications particularly removing laryngeal cancer.

What also makes the SIFLASER-1.2B highly recommended by otolaryngologists is that
it displays an accurate alignment and exact sighting during the treatment. All thanks
to its green aiming beam.

To further improve the treatment, the device is supported with a fiber guide laser.
First, it is compatible with various endoscopic uses. Second, these special fibers
are sterilizable which, in turn, prevents any possible cross-infection while guaranteeing
a clean and bloodless operative area.

With a 980nm wavelength and 15W as maximum power, the device is thought to perfectly
suit laryngeal cancer highly-sensitive surgeries.

That is highly attributed to the fact that The SIFLASER-1.2 B uses infrared wavelengths
and ultra-blue light to ensure high-level performance. That actually reduces the
thermal damage and its peculiar interaction with hemoglobin.

Due to all these features, the SIFLASER-1.2B guarantees increased cutting effectiveness,
much higher than the one obtained with infrared lasers.

Additionally, the complete absence of water absorption helps drastically reduce 
the overheating of the surrounding tissues. This should further reinforce the laser
treatment’s efficacy.

Lasers are a relatively recent addition to laryngeal surgery. Since their invention,
laser use and applications have expanded rapidly. In this article, we discuss the
benefits of laser therapy and precisely the efficacy of SIFLASER-1.2 B as a surgical
laser device in healing such diseases

.
**Reference**: [Guidance of laser therapy for early laryngeal carcinoma by mucosal wave changes](https://pubmed.ncbi.nlm.nih.gov/33040496/),

 * ![Portable-surgery-diode-laser-systems-SIFLASER-2.1B](https://sifsof.com/wp-content/
   uploads/2020/01/Portable-surgery-diode-laser-systems-SIFLASER-2.1-2-300x300.jpg)
 * FDA Portable 980nm Surgery Laser System SIFLASER-1.2B

Disclaimer: Although the information we provide is used by different doctors and
medical staff to perform their procedures and clinical applications, the information
contained in this article is for consideration only. SIFSOF is not responsible neither
for the misuse of the device nor for the wrong or random generalizability of the
device in all clinical applications or procedures mentioned in our articles. Users
must have the proper training and skills to perform the procedure with each vein
finder device.

The products mentioned in this article are only for sale to medical staff (doctors,
nurses, certified practitioners, etc.) or to private users assisted by or under 
the supervision of a medical professional